{"id":967928,"date":"2026-05-28T07:06:31","date_gmt":"2026-05-28T11:06:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sono-tek-reports-fiscal-fourth-quarter-and-full-year-2026-financial-results\/"},"modified":"2026-05-28T07:06:31","modified_gmt":"2026-05-28T11:06:31","slug":"sono-tek-reports-fiscal-fourth-quarter-and-full-year-2026-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sono-tek-reports-fiscal-fourth-quarter-and-full-year-2026-financial-results\/","title":{"rendered":"Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results"},"content":{"rendered":"
\n

\n
\n Reports Second Consecutive Year of over $20 Million in Revenue and Eighth Consecutive Quarter above $5 Million<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Significant Profitability Expansion with 51% Gross Margin for FY 2026<\/em>
\n <\/strong>\n <\/p>\n

\n
\n FY 2026 Operating Income Increased 81% and Net Income Increased 42% Year-Over-Year<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Backlog Remains Strong at $9.1 Million<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Anticipating Continued Revenue Growth in 1H 2027 Driven by Strong Medical Sector and High-ASP Systems<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Conference call scheduled for 10:30 AM ET Today<\/em>
\n <\/strong>\n <\/p>\n

MILTON, N.Y., May 28, 2026 (GLOBE NEWSWIRE) — Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the fiscal fourth quarter and full fiscal year 2026, ended February 28, 2026.<\/p>\n

\n Steve Harshbarger, CEO & President of Sono-Tek, stated:<\/strong>
\n
\u201cWe are greatly encouraged by our fiscal 2026 results, highlighted by strong profitability expansion and uninterrupted revenue consistency. We achieved our second consecutive year of revenue over $20 million and eighth consecutive quarter of revenue above $5 million, reflecting the durability and stability of our business. Additionally for FY 2026, our gross margin increased to 51%, operating income increased 81%, and net income grew by 42%, demonstrating the strength of our business model and the continuing success of our strategy focused on higher-value, high-ASP production systems.\u201d<\/p>\n

\u201cMargin expansion in the year was driven primarily by favorable product mix, including a higher concentration of high-ASP production systems, as well as a greater percentage of sales in the U.S. market, where we benefit from stronger margins by bypassing international-business costs.\u201d<\/p>\n

\u201cWe are seeing strong momentum in the medical sector, with growing demand across applications such as stent coating, balloon catheter systems, and diagnostic devices. In addition, our electronics business continues to expand, particularly in electrically active coatings for diagnostic-related applications that leverage our core coating technologies. While clean energy remains an important long-term opportunity, near-term orders for electrolysis-related systems have declined, mirroring softening demand that has resulted from government policy changes and elimination of incentives. This was partially offset by solar system shipments earlier in the fiscal year.\u201d<\/p>\n

\u201cLooking ahead, we anticipate continued revenue growth in the first half of FY 2027 and profitability driven by the medical sector and sustained demand for high-ASP production systems. For FY 2027, we anticipate relatively flat to modestly higher year over year revenue, with continued uncertainty in certain clean energy sectors and the timing of high ASP customer orders, that are more complex and typically involve longer lead times.<\/p>\n

We believe our strategy is succeeding, and we remain confident in our ability to deliver long-term revenue growth and profitability.\u201d<\/p>\n

\n Dr. Christopher L. Coccio, Executive Chairman, added:<\/strong>\n <\/p>\n

\u201cWe are pleased with the Company\u2019s continued execution and improving financial performance. We are proud to report that FY 2026 marks our third consecutive year of annual revenue growth and sixteenth year in a row of profitability. Our strong backlog, supported by demand for complex, production-oriented systems, provides a solid foundation as we move forward. Sono-Tek\u2019s ability to adapt to changing market conditions, while maintaining focus on high-value opportunities, continues to differentiate the Company. We remain confident in our long-term strategy and growth trajectory.\u201d<\/p>\n

\n
\n Fiscal Year 2026 Highlights<\/u>
\n <\/strong>\n <\/p>\n